Ratings by Morgan Stanley (Jack Lin)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/22/2025 | Hutchison China MediTech Ltd. | HCM | Downgrade | Underweight (Equalweight) |
17.45 (13.85) |
-20.63% | Details | |
| 9/27/2024 | Zai Lab | ZLAB | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2024 | Hutchison China MediTech Ltd. | HCM | Maintain | Overweight (N/A) |
|
Details | ||
| 12/14/2023 | Zai Lab | ZLAB | New Coverage | Overweight (N/A) |
26.75 (19.54) |
-26.95% | Details |
